Press Release Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca NATICK, Mass., Jan. 2, 2024 /PRNewswire/ — Allorion Therapeutics ("Allorion"), a US… CISION PRNewswireJanuary 2, 2024
Press Release It's 2024. Can Technology Drive a New Nigerian Economy? LAGOS, NG, Jan 1, 2024 – (ACN Newswire) – Some 20+ years… ACN NewswireJanuary 2, 2024
Press Release Tech Artificial Intelligence Driving Quality Control Machine Vision Market to US$7.2 Billion by 2028 NEW YORK, Jan. 2, 2024 /PRNewswire/ — Machine Vision (MV) Solutions for quality… CISION PRNewswireJanuary 2, 2024
Banking Business Press Release Tech The Path Ahead: Getting to Know One Another Better BEIJING, Jan. 2, 2024 /PRNewswire/ — A news report from China Daily… CISION PRNewswireJanuary 2, 2024
Business Press Release JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful NEW YORK, Jan. 2, 2024 /PRNewswire/ — JJ’s House, the renowned global online… CISION PRNewswireJanuary 2, 2024
Lifestyle Press Release Tech Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease LOS ANGELES, Jan. 2, 2024 /PRNewswire/ — A recent study published in… CISION PRNewswireJanuary 2, 2024
Economy Modi To Lead India Again, But Reforms To Remain Gradual Key View We expect PM Modi and the Bharatiya Janata Party to… Fitch SolutionsJanuary 2, 2024
Press Release Tech YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024 SHANGHAI, Jan. 2, 2024 /PRNewswire/ — YolTech Therapeutics, a biotech company developing… CISION PRNewswireJanuary 2, 2024
